Literature DB >> 32033765

Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives.

Manu V Chakravarthy1, Thomas Waddell2, Rajarshi Banerjee3, Nicola Guess4.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis are diseases in their own right as well as modifiable risk factors for cardiovascular disease and type 2 diabetes. With expanding knowledge on NAFLD pathogenesis, insights have been gleaned into molecular targets for pharmacologic and nonpharmacologic approaches. Lifestyle modifications constitute a cornerstone of NAFLD management. This article reviews roles of key dietary macronutrients and micronutrients in NAFLD pathogenesis and their effects on molecular targets shared with established or emerging pharmacotherapies. Based on current evidence, a recommendation for a dietary framework as part of the comprehensive management strategy for NAFLD is provided.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amino acids; Fatty acids; Fructose; Insulin resistance; NAFLD; NASH; Obesity; Protein

Year:  2019        PMID： 32033765     DOI： 10.1016/j.gtc.2019.09.003

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  14 in total

Review 1.  Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?

Authors:  Luisa Bonsembiante; Giovanni Targher; Claudio Maffeis
Journal:  Eur J Clin Nutr       Date:  2021-05-18       Impact factor: 4.016

Review 2.  Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.

Authors:  Pau Vancells Lujan; Esther Viñas Esmel; Emilio Sacanella Meseguer
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

3.  ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model.

Authors:  Ana Magdalena Velázquez; Roger Bentanachs; Aleix Sala-Vila; Iolanda Lázaro; Jose Rodríguez-Morató; Rosa M Sánchez; Marta Alegret; Núria Roglans; Juan Carlos Laguna
Journal:  Mol Nutr Food Res       Date:  2022-02-15       Impact factor: 6.575

4.  Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress.

Authors:  Masaki Tamitani; Takeshi Yamamoto; Naoki Yamamoto; Koichi Fujisawa; Shinji Tanaka; Yoshihide Nakamura; Hitoshi Uchinoumi; Tetsuro Oda; Shinichi Okuda; Taro Takami; Shigeki Kobayashi; Isao Sakaida; Masafumi Yano
Journal:  Biochem Biophys Rep       Date:  2020-07-21

5.  A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets.

Authors:  Chiao-Wei Lin; Ting-Wei Huang; Yu-Ju Peng; Yuan-Yu Lin; Harry John Mersmann; Shih-Torng Ding
Journal:  Poult Sci       Date:  2020-11-30       Impact factor: 3.352

6.  Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19.

Authors:  Adriana Roca-Fernández; Andrea Dennis; Rowan Nicholls; John McGonigle; Matthew Kelly; Rajarshi Banerjee; Amitava Banerjee; Arun J Sanyal
Journal:  Front Med (Lausanne)       Date:  2021-03-29

7.  Spinach consumption and nonalcoholic fatty liver disease among adults: a case-control study.

Authors:  Ebrahim Mokhtari; Hossein Farhadnejad; Ammar Salehi-Sahlabadi; Narjes Najibi; Mina Azadi; Farshad Teymoori; Parvin Mirmiran
Journal:  BMC Gastroenterol       Date:  2021-05-01       Impact factor: 2.847

8.  Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD.

Authors:  Charles I V Drummer; Fatma Saaoud; Yu Sun; Diana Atar; Keman Xu; Yifan Lu; Ying Shao; Candice Johnson; Lu Liu; Huimin Shen; Nirag C Jhala; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  J Immunol Res       Date:  2021-11-23       Impact factor: 4.818

Review 9.  Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov; Aleksei Bulgakov
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

10.  Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.

Authors:  Shuhua Shen; Kungen Wang; Yihui Zhi; Wei Shen; Liquan Huang
Journal:  Cell Cycle       Date:  2020-10-29       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.